PI3K block restores age-dependent neurovascular coupling defects associated with cerebral small vessel disease

R. A. Corriveau et al., The science of vascular contributions to cognitive impairment and dementia (VCID): A framework for advancing research priorities in the cerebrovascular biology of cognitive decline. Cell Mol. Neurobiol. 36281–288 (2016).

J. M. Wardlaw, C. Smith, M. Dichgans, Mechanisms of sporadic cerebral small vessel disease: Insights from neuroimaging. Lancet Neurol. 12483–497 (2013).

S. Debette, S. Schilling, M. G. Duperron, S. C. Larsson, H. S. Markus, Clinical significance of magnetic resonance imaging markers of vascular brain injury a systematic review and meta-analysis. Jama Neurol. 7681–94 (2019).

M. Dichgans, D. Leys, Vascular cognitive impairment. circ. Beef. 120573–591 (2017).

Y. Shi, J. M. Wardlaw, Update on cerebral small vessel disease: A dynamic whole-brain disease. Stroke Vasc. Neurol. 183–92 (2016).

L. E. Evans et al., Cardiovascular comorbidities, inflammation, and cerebral small vessel disease. Cardiovasc. Res. 1172575–2588 (2021).

M. van Dinther et al., Extracerebral microvascular dysfunction is related to brain MRI markers of cerebral small vessel disease: The maastricht study. Geroscience 44147–157 (2022).

A. Jokumsen-Cabral, A. Aires, S. Ferreira, E. Azevedo, P. Castro, Primary involvement of neurovascular coupling in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J. Neurol. 2661782–1788 (2019).

C. S. Roy, C. S. Sherrington, On the regulation of the blood-supply of the brain. J. Physiol. 1185–158.117 (1890).

M. Jeanne, D. B. Gould, Genotype-phenotype correlations in pathology caused by collagen type IV alpha 1 and 2 mutations. Matrix Biol. 57–5829–44 (2017).

M. Mao, M. V. Alavi, C. Labelle-Dumais, D. B. Gould, Type IV collagens and basement membrane diseases: Cell biology and pathogenic mechanisms. Curr. Top. Membr. 7661–116 (2015).

D. S. Kuo, C. Labelle-Dumais, D. B. Gould, COL4A1 and COL4A2 mutations and disease: Insights into pathogenic mechanisms and potential therapeutic targets. Hum. Mol. Genet. 21R97–R110 (2012).

M. Mao et al., Identification of fibronectin 1 as a candidate genetic modifier in a Col4a1 mutant mouse model of Gould syndrome. Dis. Model. Mech. 14dmm048231 (2021).

C. Iadecola, The neurovascular unit coming of age: A journey through neurovascular coupling in health and disease. Neuron 9617–42 (2017).

H. Girouard et al., Astrocytic endfoot Ca2+ and BK channels determine both arteriolar dilation and constriction. Proc. Natl. Acad. Sci. U.S.A. 1073811–3816 (2010).

G. C. Petzold, D. F. Albeanu, T. F. Sato, V. N. Murthy, Coupling of neural activity to blood flow in olfactory glomeruli is mediated by astrocytic pathways. Neuron 58897–910 (2008).

C. Iadecola, M. Nedergaard, Glial regulation of the cerebral microvasculature. Nat. Neurosci. 101369–1376 (2007).

T. A. Longden et al., Capillary K(+)-sensing initiates retrograde hyperpolarization to increase local cerebral blood flow. Nat. Neurosci. 20717–726 (2017).

P. Thakore et al., Brain endothelial cell TRPA1 channels initiate neurovascular coupling. Elife 10e63040 (2021).

P. J. Drew, C. Mateo, K. L. Turner, X. Yu, D. Kleinfeld, Ultra-slow oscillations in fMRI and resting-state connectivity: Neuronal and vascular contributions and technical confounds. Neuron 107782–804 (2020).

L. Kaplan, B. W. Chow, C. H. Gu, Neuronal regulation of the blood-brain barrier and neurovascular coupling. Nat. Rev. Neurosci. 21416–432 (2020).

F. Dabertrand et al., PIP2 corrects cerebral blood flow deficits in small vessel disease by rescuing capillary Kir2.1 activity. Proc. Natl. Acad. Sci. U.S.A. 118e2025998118 (2021).

C. L. Huang, S. Feng, D. W. Hilgemann, Direct activation of inward rectifier potassium channels by PIP2 and its stabilization by Gbetagamma. Nature 391803–806 (1998).

S. B. Hansen, X. Tao, R. MacKinnon, Structural basis of PIP2 activation of the classical inward rectifier K+ channel Kir2.2. Nature 477495–U152 (2011).

D. S. Kuo et al., Allelic heterogeneity contributes to variability in ocular dysgenesis, myopathy and brain malformations caused by Col4a1 and Col4a2 mutations. Hum. Mol. Genet. 231709–1722 (2014).

RJ Cannistraro et al., CNS small vessel disease: A clinical review. Neurology 921146–1156 (2019).

S. Hilal et al., Prevalence, risk factors and consequences of cerebral small vessel diseases: Data from three Asian countries. J. Neurol. Neurosurg. Psychiatry 88669–674 (2017).

H. J. Knot, P. A. Zimmermann, M. T. Nelson, Extracellular K(+)-induced hyperpolarizations and dilatations of rat coronary and cerebral arteries involve inward rectifier K(+) channels. J. Physiol. 492419–430 (1996).

F. Dabertrand et al., Potassium channelopathy-like defect underlies early-stage cerebrovascular dysfunction in a genetic model of small vessel disease. Proc. Natl. Acad. Sci. U.S.A. 112E796–E805 (2015).

C. F. Wenceslau et al., Guidelines for the measurement of vascular function and structure in isolated arteries and veins. Am. J. Physiol. Heart Circ. Physiol. 321H77–H111 (2021).

M. Jeanne, J. Jorgensen, D. B. Gould, Molecular and genetic analyses of collagen Type IV mutant mouse models of spontaneous intracerebral hemorrhage identify mechanisms for stroke prevention. Circulation 1311555–1565 (2015).

E. Yamasaki et al., Faulty TRPM4 channels underlie age-dependent cerebral vascular dysfunction in Gould syndrome. Proc. Natl. Acad. Sci. U.S.A. 120e2217327120 (2023).

H. Girouard et al., Astrocytic endfoot Ca2+ and BK channels determine both arteriolar dilation and constriction. Proc. Natl. Acad. Sci. U.S.A. 1073811–3816 (2010).

L. Park et al., Age-dependent neurovascular dysfunction and damage in a mouse model of cerebral amyloid angiopathy. Stroke 451815–1821 (2014).

S. Tarantini et al., Pharmacologically-induced neurovascular uncoupling is associated with cognitive impairment in mice. J. Cereb. Blood Flow Metab. 351871–1881 (2015).

A. K. Kraeuter, P. C. Guest, Z. Sarnyai, The Y-maze for assessment of spatial working and reference memory in mice. Methods Mol. Biol. 1916105–111 (2019).

M. Ohno et al., BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer’s disease. Neuro n 4127–33 (2004).

H. Oakley et al., Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: Potential factors in amyloid plaque formation. J. Neurosci. 2610129–10140 (2006).

A. K. Swonger, R. H. Rech, Serotonergic and cholinergic involvement in habituation of activity and spontaneous alternation of rats in a Y maze. J. Comp. Physiol. Psychol. 81509–522 (1972).

Z. Sarnyai et al., Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors. Proc. Natl. Acad. Sci. U.S.A. 9714731–14736 (2000).

A. Mughal, O. F. Harraz, A. L. Gonzales, D. Hill-Eubanks, M. T. Nelson, PIP2 improves cerebral blood flow in a mouse model of alzheimer’s disease. Function (Oxf) 2zqab010 (2021).

S. Suer, A. Sickmann, H. E. Meyer, F. W. Herberg, L. M. Heilmeyer Jr., Human phosphatidylinositol 4-kinase isoform PI4K92. Expression of the recombinant enzyme and determination of multiple phosphorylation sites. Eur. J. Biochem. 2682099–2106 (2001).

A. Balla, T. Balla, Phosphatidylinositol 4-kinases: Old enzymes with emerging functions. Trends Cell Biol. 16351–361 (2006).

T. Gehrmann et al., Functional expression and characterisation of a new human phosphatidylinositol 4-kinase PI4K230. Biochim. Biophys. Acta 1437341–356 (1999).

O. F. Harraz, T. A. Longden, F. Dabertrand, D. Hill-Eubanks, M. T. Nelson, Endothelial GqPCR activity controls capillary electrical signaling and brain blood flow through PIP2 depletion. Proc. Natl. Acad. Sci. U.S.A. 115E3569–E3577 (2018).

R. Mishra, H. Patel, S. Alanazi, M. K. Kilroy, J. T. Garrett, PI3K Inhibitors in cancer: Clinical implications and adverse effects. Int. J. Mol. Sci. 223464 (2021).

S. Zagaglia et al., Neurologic phenotypes associated with COL4A1/2 mutations: Expanding the spectrum of disease. Neurology 91e2078–e2088 (2018).

M. E. Meuwissen et al., The expanding phenotype of COL4A1 and COL4A2 mutations: Clinical data on 13 newly identified families and a review of the literature. The gene. With. 17843–853 (2015).

M. Jeanne, D. B. Gould, Genotype-phenotype correlations in pathology caused by collagen type IV alpha 1 and 2 mutations. Matrix Biol. 57–5829–44 (2017).

D. S. Kuo, C. Labelle-Dumais, D. B. Gould, COL4A1 and COL4A2 mutations and disease: Insights into pathogenic mechanisms and potential therapeutic targets. Hum. Mol. Genet. 21R97–R110 (2012).

C. Labelle-Dumais et al., COL4A1 mutations cause neuromuscular disease with tissue-specific mechanistic heterogeneity. Am. J. Hum. Genet. 104847–860 (2019).

N. Verzijl et al., Effect of collagen turnover on the accumulation of advanced glycation end products. J. Biol. Chem. 27539027–39031 (2000).

R. Nissen, G. J. Cardinale, S. Udenfriend, Increased turnover of arterial collagen in hypertensive rats. Proc. Natl. Acad. Sci. U.S.A. 75451–453 (1978).

P. K. Mays, R. J. McAnulty, J. S. Campa, G. J. Laurent, Age-related changes in collagen synthesis and degradation in rat tissues. Importance of degradation of newly synthesized collagen in regulating collagen production. Biochem. J. 276307–313 (1991).

R. P. Boot-Handford, M. Kurkinen, D. J. Prockop, Steady-state levels of mRNAs coding for the type IV collagen and laminin polypeptide chains of basement membranes exhibit marked tissue-specific stoichiometric variations in the rat. J. Biol. Chem. 26212475–12478 (1987).

M. Mao, C. Labelle-Dumais, S. F. Tufa, D. R. Keene, D. B. Gould, Elevated TGFbeta signaling contributes to ocular anterior segment dysgenesis in Col4a1 mutant mice. Matrix Biol. 110151–173 (2022).

A. V. Bakin, A. K. Tomlinson, N. A. Bhowmick, H. L. Moses, C. L. Arteaga, Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 27536803–36810 (2000).

I. Shin, A. V. Bakin, U. Rodeck, A. Brunet, C. L. Arteaga, Transforming growth factor beta enhances epithelial cell survival via Akt-dependent regulation of FKHRL1. Mol. Biol. Cell 123328–3339 (2001).

K. Hara et al., Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N. Engl. J. Med. 3601729–1739 (2009).

J. Favor et al., Type IV procollagen missense mutations associated with defects of the eye, vascular stability, the brain, kidney function and embryonic or postnatal viability in the mouse, Mus musculus: An extension of the Col4a1 allelic series and the identification of the first two Col4a2 mutant alleles. Genetics 175725–736 (2007).